naltrexone has been researched along with dezocine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Picker, MJ | 1 |
| Chai, JR; Dong, H; Huang, X; Liu, GY; Long, JD; Ma, Y; Wang, YH; Wang, YJ; Xiao, ZC; Xu, XJ; Ye, RF; Zan, GY | 1 |
| Chang, N; Chang, S; Duan, C; Jia, S; Shang, L | 1 |
4 other study(ies) available for naltrexone and dezocine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists.
Topics: Analgesics, Opioid; Animals; Bridged Bicyclo Compounds, Heterocyclic; Columbidae; Cycloparaffins; Discrimination Learning; Female; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Opioid, mu; Tetrahydronaphthalenes | 1997 |
Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist.
Topics: Analgesics, Opioid; Animals; Bridged Bicyclo Compounds, Heterocyclic; CHO Cells; Cricetulus; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Male; Mice; Morphine; Naltrexone; Narcotic Antagonists; Nociception; Pain Measurement; Protein Binding; Receptors, Opioid, kappa; Receptors, Opioid, mu; Signal Transduction; Tetrahydronaphthalenes | 2018 |
Antidepressant-like effects of dezocine in mice: involvement of 5-HT1A and κ opioid receptors.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Mice; Naltrexone; Piperazines; Pyridines; Receptors, Opioid, kappa; Receptors, Opioid, mu; Serotonin 5-HT1 Receptor Antagonists; Tetrahydronaphthalenes; Treatment Outcome | 2021 |